In this study, we combined linkage analysis with whole-exome sequencing of two individuals to identify candidate causal variants in a moderately-sized UK kindred exhibiting autosomal-dominant inheritance of craniocervical dystonia. Subsequent screening of these candidate causal variants in a large number of familial and sporadic cases of cervical dystonia led to the identification of a total of six putatively pathogenic mutations in ANO3, a gene encoding a predicted Ca 2þ -gated chloride channel that we show to be highly expressed in the striatum. Functional studies using Ca 2þ imaging in case and control fibroblasts demonstrated clear abnormalities in endoplasmic-reticulum-dependent Ca 2þ signaling. We conclude that mutations in ANO3 are a cause of autosomal-dominant craniocervical dystonia. The locus DYT23 has been reserved as a synonym for this gene. The implication of an ion channel in the pathogenesis of dystonia provides insights into an alternative mechanism that opens fresh avenues for further research.
Introduction
Cervical dystonia is the most common form of focal dystonia seen by neurologists. 1 Previous epidemiological studies conducted in Europe and Northern England have suggested a prevalence of 5.7-6.1 per 100,000 persons.
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Although lifespan is not generally reduced, individuals affected by the condition can suffer considerable physical and psychosocial distress, which has been shown to have a significant impact on their quality of life. 4 Treatment remains symptomatic, and regular injections of botulinum toxin constitute the mainstay of current medical therapy. Genetic factors are believed to play an important role in the pathogenesis of cervical dystonia given that around 10%-20% of affected individuals have one or more affected family members. 5, 6 Despite this fact, a later age of onset and characteristically reduced penetrance have made it difficult to identify kindreds of a size sufficient to permit traditional linkage-based approaches to gene identification. So far, mutations in two genes (TOR1A [MIM 605204 ] and THAP1 [MIM 609520]) have been conclusively shown to cause autosomal-dominant primary dystonia. 7, 8 Even together, however, mutations in these genes explain only a small fraction of familial dystonia, suggesting that a number of genetic factors remain to be identified. More recently, mutations is CIZ1 (MIM 611420) have also been suggested as a cause of adult-onset cervical dystonia, 9 although this has yet to be confirmed by others.
In this study, we combined linkage analysis with wholeexome sequencing of two individuals to identify candidate causal variants in a moderately-sized UK kindred exhibiting autosomal-dominant inheritance of primary craniocervical dystonia 10 (TOR1A and THAP1 had previously been excluded). We performed Sanger sequencing of the candidate variant in a large number of dystonia samples and subsequent next-generation targeted sequencing of the whole gene to provide a comprehensive genetic screening of phenotypically similar cases.
Subjects and Methods

The Index Family
All samples were collected with the written consent of participants and formal ethical approval by the relevant research ethics committee. All living individuals from the index family were reexamined and videoed as part of this study, and the two now deceased individuals had been examined and videoed as part of a previous study. 10 The family pedigree is shown in Figure 1 . All family members shown are over 25 years of age. Upon examination, all definitely affected family members exhibited tremulous cervical dystonia with a variable degree of associated upper-limb dystonic tremor. In addition, family members II-7 and III-7 had laryngeal involvement, and family member II-4 had both laryngeal involvement and blephrospasm (see Movie S1, available online). Age of onset ranged from 19-39 years, and most had onset in the last few years of their fourth decade. One family member, II-1, had additional neurological signs on examination: he exhibited mild truncal ataxia, dysarthria, and mild cognitive impairment, all dating from an episode of Wernicke-Korsakoff's encephalopathy 6 years previously. His family confirmed that he had consumed alcohol excessively for much of his life prior to that episode.
There was no evidence of dystonia or any other neurological signs in any definitely unaffected individual. The affectation status of one individual, represented by a circle with a question mark in the center (III-2 in Figure 1A ), was uncertain. She described neck pain with a tight, pulling sensation on the lefthand side. Examination revealed a subtle left-sided torticollis, but no tremor. Given that onset for all but one member of the family affected by the disease had been in the late 30s and that she was currently 46, it was felt possible that these symptoms and examination findings might represent an early stage or a forme fruste of the condition, and so for the purpose of linkage analysis, her affectation status was set to unknown.
Genomic DNA extracted from whole blood was available for the analysis of 15 individuals. DNA from individuals III-8 and III-10 was only obtained at a late stage and was not available for linkage, but it was used for segregation analysis.
Linkage Analysis
Linkage analysis was performed by SNP genotyping with the CytoSNP-12 chip (Illumina, San Diego, CA, USA). Data from 5,652 markers, spaced at approximately equal distances across the genome, were analyzed with MERLIN (Multipoint Engine for Rapid Likelihood Inference) v.1.1.2. For the parametric analysis, LOD scores were calculated under the model of an autosomal-dominant disease with a penetrance of 80%. This produced five linkage peaks with an identical maximum LOD score of 2.01 on chromosomes 4, 5, 6, 7, and 11. The plot of LOD scores against chromosome positions is shown in Figure S1 . For the five peaks with the highest LOD scores, the size of each region and number of genes contained therein are summarized in Table S1 .
Whole-Exome Sequencing and Variant Calling
Three micrograms of genomic DNA from the two most distantly related, definitely affected family members (individuals II-1 and III-7) was sent to BGI (Shenzhen, China) for whole-exome capture and sequencing. This generated 57,506,202 (II-1) and 30,644,686 (III-7) unique reads per exome, translating to a total variant count of 20,935 and 17,024, respectively. According to the Consensus Coding Sequences hg19 definition of the exome, coverage was 90% and 83% for at least two reads, and the mean read depth across the exome was 46 and 45 reads, respectively. 
Targeted Next-Generation Sequencing of ANO3
We performed targeted high-throughput sequencing of ANO3 in 188 dystonia-affected proband samples by using the MiSeq next-generation-sequencing machine and the TruSeq Custom Amplicon kit, both supplied by Illumina. A full and detailed protocol is supplied by Illumina. In brief, custom oligonucleotides targeting all 27 ANO3 exons (including both UTRs) were created with Illumina Design Studio. At least 25 intronic bases were included from either side of each exon. The hybridization of the oligonucleotide probes to unfragmented genomic DNA was carried out in 96-well plates and was followed by extension and ligation for the formation of DNA templates consisting of regions of interest flanked by universal primer sequences. Each plate contained 94 samples of interest, one positive control from the initial family, and one unrelated Illumina technical control well. Two hundred fifty micrograms of DNA was used as the input for the hybridization reaction. Indices and sequencing adapters supplied by Illumina were then joined by PCR reaction as per the protocol supplied with the kit. Finally, the PCR product was purified, normalized, pooled in a single tube, and sequenced on the MiSeq system. Base calling and annotation were performed by the in-built MiSeq reporter software. The average cluster density was~700 K/mm 3 , and 93% of the clusters passed quality control. No regions of the gene were poorly covered, and the average read depth across all samples was 951 reads. 
Expression Profiling of ANO3 in Brain Tissue
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A full description of the samples used and the methods of RNA isolation and processing can be found in Trabzuni et al., 2011.
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As previously described, all arrays were preprocessed with robustmultiarray-average quantile normalization with GC background correction and log2 transformation in Partek's Genomics Suite v.6.6 (Partek, St. Louis, MO, USA). 14,15 Regional differences in gene-level expression were investigated with Partek's mixedmodel ANOVA, and gender and batch effects (date of hybridization and brain bank) were included as cofactors.
Ca 2þ Imaging in Fibroblasts from Affected Individuals
After signed consent, fibroblasts were obtained from a skin biopsy from an affected individual carrying the c.1470G>C (p.Trp490Cys) mutation in ANO3. Age-and passage-matched controls were selected from in-house cell lines. The fibroblasts were cultured in Dulbecco's modified Eagle's medium GlutaMAX supplemented with 10% (v/v) heat-inactivated fetal bovine serum and 1% penicillin strepomycin. They were maintained at 37 C in a humidified atmosphere of 5% CO 2 and 95% air. ] c . Cells were loaded for 30 min at room temperature with 5 mM fura-2 AM and 0.005% Pluronic in a HEPES-buffered salt solution composed of 156 mM NaCl, 3 mM KCl, 2 mM MgSO 4 , 1.25 mM KH 2 PO 4 , 2 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES (pH was adjusted to 7.35 with NaOH). Ca 2þ -free medium contained 0.5 mM EGTA. All analyzed areas were chosen at random, and three independent experiments were performed for each condition. The number of cells analyzed for each set of experiments is indicated in the Results below.
Fluorescence measurements were obtained on an epifluorescence inverted microscope equipped with a 203 fluorite objective. [Ca 2þ ] c was monitored in single cells with excitation light provided by a Xenon arc lamp, and the beam passed through a monochromator at 340 and 380 nm (Cairn Research, Kent, UK). Emitted fluorescence light was reflected through a 515 nm longpass filter to a cooled charged-coupled-device camera (Retiga, QImaging, Surrey, BC, Canada) and digitized to a 12 bit resolution. All imaging data were collected and analyzed with software from Andor (Belfast, UK). The fura-2 data were not calibrated in terms of [Ca 2þ ] c because of the uncertainty arising from the use of different calibration techniques. ATP (100 mM) was used for stimulating [Ca 2þ ] c signals in fibroblasts via purinoceptors and for releasing calcium from the endoplasmic reticulum (ER) via IP3 receptors. Fifty millimolars of KCl was used for inducing depolarization of the plasma membrane and for opening voltage-gated calcium channels. Thapsigargin (1 mM) in Ca 2þ -free medium (plus 0.5 mM EGTA) was used for inducing the release of calcium from the ER to the cytosol and thus for estimating the size of the reticular Ca 2þ pool.
Results
Variant analysis of exome-sequencing data was based on the assumption that the mutation causing this uncommon, heritable form of the disease in this family would not be present in the general population at an appreciable frequency. In order to maximize the chances of isolating the causal variant and to minimize the chances of error in assignment, we employed two different strategies to select candidate causal variants. The first strategy involved selecting only those variants that were present in the exome data of both affected family members for analysis. Homozygous variants, synonymous variants, and variants recorded in dbSNP135 were initially removed. We then filtered out any variant present at a global minor allele frequency (MAF) R 1% in a range of publically available databases of sequence variation (1000 Genomes, Complete Genomic 69 Database, and the National Heart, Lung, and Blood Institute [NHLBI] Exome Sequencing Project database), as well as those found in two or more of our own in-house exomes from individuals (n ¼ 200) with unrelated diseases. Finally, variants within the regions under the linkage peaks with the highest LOD scores (on chromosomes 4, 5, 6, 7, and 11; see Table S1 for definition of regions) were validated by Sanger sequencing in the forward and reverse directions with the use of BigDye Terminator v. In addition, the individual of uncertain affectation status was also seen to carry the variant. The mutation occurred at a base that was highly conserved between species (see Figure 2 ), resulting in a change from arginine to tryptophan at position 494 of the protein, and was predicted to be damaging by MutationTaster, SIFT, and PolyPhen-2. In order to compensate for any unequal coverage between the two exomes, we employed a second strategy, in which all variants from the exome with the best coverage were first filtered as above, to produce a list of 
R 1%. We then discarded any variants that were not in areas covered by the linkage peaks with the highest LOD scores (see Table S1 ). For each remaining variant in turn, we then visually inspected the data for the other exome to ensure that it had been covered. If it had not been covered adequately (as in the case of two variants), the exon of the gene containing the variant was Sanger sequenced and, if present, checked for segregation in the rest of the family. The results are detailed in Table S2 , but in summary, this strategy did not identify any new candidate variants that segregated with the disease.
Screening of ANO3 Exon 15 in Additional Cases
Revealed a Second Segregating Mutation We next took our best candidate variant in exon 15 of ANO3 and Sanger sequenced the exon in a selection of phenotypically similar cases. As an additional check, in the same selection of cases, we also sequenced the exons containing the variant of the two genes (TBC1D7 and TMEM232) that had failed to segregate solely because of the presence of the variant in a single unaffected individual. We did this to account for the possibility of a reduced penetrance, which appears to be common in dystonia. DNA samples for sequencing were obtained from an in-house library of previously donated samples from individuals who had given research consent. Samples were selected on the basis that the accompanying clinical description suggested cervical dystonia and/or dystonic upper-limb tremor. Both familial (n ¼ 137) and sporadic (n ¼ 247) cases were selected for inclusion. Samples that were known to have previously tested positive for TOR1A or THAP1 were excluded. We also included a small number of samples from individuals for whom the primary clinical impression had been of familial essential tremor or myoclonus dystonia (provided they tested negative for mutations in SGCE [MIM 604149]) because it was felt that these clinical phenotypes might easily be confused with upperlimb dystonic tremor or jerky cervical dystonia, respectively. 17 A total of 384 samples were screened.
Analysis of the sequence traces for these 384 individuals revealed no potentially pathogenic variants in exon 2 of TBC1D7 or exon 10 of TMEM232. In exon 15 of ANO3, however, we found a second heterozygous missense mutation (c.1470G>C [p.Trp490Cys]) in the same highly conserved region in which the mutation in the index family was located (see Figure 2) ; this second mutation was also predicted to be damaging by SIFT, PolyPhen-2, and MutationTaster. It was not present in the data from the NHLBI Exome Sequencing Project (4,090 5 627 samples of European ancestry at a read depth of 80 5 40), 1000 Genomes Project, or our own in-house exomes (n ¼ 200). The phenotype of the individual (IV-2 in Figure 1B ) in whom the mutation was found was almost identical to that of the initial index family; she had tremulous cervical dystonia with laryngeal involvement and a dystonic tremor of the upper limbs (see Movie S2). Onset was in the early teens, and the fact that her brother and father were also affected suggests autosomal-dominant inheritance. DNA samples were obtained from all available members of the family, which confirmed that both the father (III-1) and brother (IV-1) carried the variant but that the father's unaffected brother (III-3) did not. Interestingly, her paternal great grandmother (I-1), but not her paternal grandmother (II-1), was reported to have been affected by head tremor. Although both individuals are now deceased and could not be examined, this suggests the possibility that penetrance might not be complete.
High-Throughput Sequencing of the Whole ANO3 Reveals Four Additional Variants
On the basis of the finding of a second mutation, we performed targeted high-throughput sequencing of ANO3 in 188 samples by using the MiSeq next-generationsequencing machine and the TruSeq Custom Amplicon kit, both supplied by Illumina. A total of 110 familial and 78 sporadic samples, selected as above, were screened.
We identified four putative pathogenic variants: three missense variants in exons 2, 21, and 25 and a variant in the 5 0 UTR (summarized in Table 1 and shown on Figure S2 ). None of these variants were seen in the publically available data from the NHLBI Exome Sequencing Project, 1000 Genomes Project, or our own in-house exomes. In silico predictions of their pathogenicity by MutationTaster, SIFT, and PolyPhen-2 were, however, contradictory (see Table 1 for individual results). Clinically, two of the four individuals had cervical dystonia, and three of the four individuals had upper-limb tremor. The individual carrying a mutation (c.2053A>G [p.Ser685Gly]) in exon 21 of ANO3 had a clear autosomal-dominant history of cervical, laryngeal, and upper-limb tremulous dystonia (see Figure 1C) . She (II-1), her mother (I-2), and her son (III-1) had all developed symptoms in their first decade of life. We were able to obtain DNA samples from her mother and son; both individuals were heterozygous for the c.2053A>G mutation. Her father was homozygous for the normal allele. She also reported one unaffected sister and one sister who developed laryngeal dystonia in her late twenties. Unfortunately, these individuals currently reside outside of the UK, and it was not possible to obtain DNA from them. We were also unable to obtain DNA for segregation for the variants in the UTR, exon 2, or exon 25 either because of social circumstances or because the affected relatives were deceased or did not wish to take part in the study.
ANO3 Is Most Highly Expressed in the Striatum
We then investigated the expression of ANO3 in brain and CNS tissues by using in-house data from the UK Brain Expression Consortium. The regional distribution of ANO3 mRNA expression at the gene level is shown in Figure 3A . This demonstrated significant regional differences in ANO3 mRNA expression: there was an 5.3-fold difference (p value < 1.0 3 10 À45 ) between the putamen, the highest ANO3-expressing region, and the frontal cortex, the region with the second highest expression, and there was a 70-fold difference in expression between the putamen and the cerebellum, the region with the lowest expression (p value < 1.0 3 10 À45 ). Figure 4B ). Thus, in response to ATP, the ANO3 mutation resulted in a reduced calcium signal, which can most likely be explained by a smaller calcium pool within the ER. The similar responses in control and mutation-carrying cells seen upon depolarization of the plasma membrane suggest that the mutation does not modulate voltage-gated calcium channels or active Ca 2þ transport (the mechanism of calcium removal from the cytosol).
To confirm these findings, we performed further experiments by using thapsigargin (1 mM) in Ca 2þ -free medium (plus 0.5 mM EGTA). The addition of thapsigargin, which is an inhibitor of the sarcoplasmic ER calcium ATPase, induces a release of calcium from the ER to the cytosol and can be used for estimating the reticular Ca 2þ -pool.
Adding Ca 2þ at the end of the experiment stimulated elevation of [Ca 2þ ] c in fibroblasts ( Figure 4C ) as a result of the opening of store-operated calcium channels. We found that the calcium signal in response to thapsigargin in fibroblasts carrying the c.1470G>C (p.Trp490Cys) mutation was significantly smaller (n ¼ 26; p < 0.001; Figures 4C and 4D ) than that in ctrl 1 (n ¼ 19) and ctrl 2 (n ¼ 22). This strongly suggests that the thapsigarginsensitive Ca 2þ pool in the ER of mutation-carrying fibroblasts is significantly smaller than that in control cells. Stimulation of the store-operated Ca 2þ channels induced similar elevation of [Ca 2þ ] c in control and mutated fibroblasts ( Figures 4C and 4D ).
Discussion
In a moderately-sized UK kindred affected by apparently autosomal-dominant craniocervical dystonia and dystonic 27 and mutations in ANO6 (MIM 608663) have been linked to Scott syndrome, a rare bleeding disorder.
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ANO1 and ANO2 (MIM 610109), the best studied members of the family, encode proteins that function as Ca 2þ -activated chloride channels (CaCCs). 29 It remains an open question as to whether anoctamin 3 functions in the same manner. Hydropathy analysis suggests a similar topology-eight hydrophobic helices have been found to be likely transmembrane domains and cytosolic N and C termini (see Figure S2 )-but more recent work has suggested that anoctamin 3 might in fact be targeted to the ER rather than to the cell surface (like anoctamins 1 and 2). 20 CaCCs are, nonetheless, known to have a role in the modulation of neuronal excitability, 30, 31 and, in view of our data showing very high expression of ANO3 in the striatum, it is possible that mutations in this gene lead to abnormal striatal-neuron excitability, which manifests itself clinically in unwanted dystonic movements. In this regard, it is interesting to note that the two mutations that we found in exon 15 lead to amino acid changes within a predicted cytosolic loop that some have suggested might function as the Ca 2þ sensor. 21 Indeed, mutations in the homologous loop of AN03's sister gene, ANO2, have recently been shown to alter the voltage dependence of channel activation. 32 Our own data from fibroblasts carrying a mutation in exon 15 of ANO3 confirm abnormalities in Ca 2þ signaling. The lack of a difference in Ca 2þ response to KCl, which would be expected to open ion channels in the plasmalemma in the context of a significantly reduced response to two agents known to cause calcium release from the ER (ATP and, more specifically, thapsigargin), suggests a potential defect in ER-related Ca 2þ handling in these mutation-bearing fibroblasts.
A third mutation (c.2053A>G [p.Ser685Gly]) was found in the loop between the fifth and sixth transmembrane domains of the protein (see Figure S2) . In anoctamin 1, it is thought that this loop might form a critical component of the channel pore, 33 although there is debate about whether this loop is extracellular, reentrant, or cytosolic. 34 If anoctamin 3 were also proven to function as an ion channel, this work might suggest a possible mechanism by which an amino acid substitution in this loop could confer pathogenicity. Although further functional work will be required for establishing the mechanism by which mutations in ANO3 might lead to dystonia, the implication of a transmembrane ion channel in the pathogenesis of this condition represents a completely fresh avenue of inquiry for future research in this field and, importantly, raises the possibility that pharmaceutical agents targeted at compensating for aberrant channel function could potentially be beneficial in the treatment of a subset of dystonia-affected individuals. For instance, CaCCs can be blocked in vitro by nifulmic acid, by tamoxifen, and, to a lesser extent and in a less specific manner, by fluoxetine. 31 Finally, it will be important to carry out further genetic screening of phenotypically similar cases in this and other populations in order to establish the prevalence of mutations in this gene as a cause of autosomal-dominant cervical dystonia, dystonic head tremor, and/or upper-limb dystonic tremor.
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